6-aminonicotinamide, a G6PD inhibitor, can decrease mammosphere formation and aldehyde dehydrogenase (ALDH) activity when given with DHEA in breast cancer stem-like cells that show high PPP activity (Debeb et al., 2016). This evidence concerns the gene LDHA and breast cancer.